Milestone Pharmaceuticals (MIST) Free Cash Flow: 2018-2024
Historic Free Cash Flow for Milestone Pharmaceuticals (MIST) over the last 7 years, with Dec 2024 value amounting to -$28.9 million.
- Milestone Pharmaceuticals' Free Cash Flow fell 4.81% to -$13.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$52.7 million, marking a year-over-year decrease of 58.57%. This contributed to the annual value of -$28.9 million for FY2024, which is 37.94% up from last year.
- As of FY2024, Milestone Pharmaceuticals' Free Cash Flow stood at -$28.9 million, which was up 37.94% from -$46.5 million recorded in FY2023.
- In the past 5 years, Milestone Pharmaceuticals' Free Cash Flow ranged from a high of -$28.9 million in FY2024 and a low of -$52.7 million during FY2022.
- For the 3-year period, Milestone Pharmaceuticals' Free Cash Flow averaged around -$42.7 million, with its median value being -$46.5 million (2023).
- Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 58.74% in 2022, then spiked by 37.94% in 2024.
- Milestone Pharmaceuticals' Free Cash Flow (Yearly) stood at -$50.7 million in 2020, then surged by 34.51% to -$33.2 million in 2021, then tumbled by 58.74% to -$52.7 million in 2022, then increased by 11.77% to -$46.5 million in 2023, then surged by 37.94% to -$28.9 million in 2024.